Company Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 76 | 13-01-31 | |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Chief Tech/Sci/R&D Officer | - | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 18-06-25 |
Sol Barer
FOU | Founder | 76 | 13-01-31 |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 13-01-31 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 18-08-14 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 18-12-31 |
Founder | 76 | 13-01-31 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 17-12-31 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 17-06-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,669,866 | 0 | 0 | - |
Company contact information
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |